Are We Close to Zeroing the Ventilator-associated Pneumonia Rate?

Basit Öğe Kaydı
dc.authorscopusid57199861771
dc.authorscopusid57720739400
dc.authorscopusid57720739500
dc.authorscopusid57720812300
dc.authorscopusid6507387307
dc.authorscopusid57720849600
dc.authorscopusid6603926069
dc.authorwosidSipahi, Oguz Resat/AAR-2916-2020
dc.contributor.authorBulut Avsar, Cansu
dc.contributor.authorDikis, Demet
dc.contributor.authorKorkmaz Erken, Pervin
dc.contributor.authorBahcivan, Esra
dc.contributor.authorBacakoglu, Feza
dc.contributor.authorSipahi, Oguz Resat
dc.contributor.authorUlusoy, Sercan
dc.date.accessioned2023-01-12T20:16:49Z
dc.date.available2023-01-12T20:16:49Z
dc.date.issued2022
dc.departmentN/A/Departmenten_US
dc.description.abstractIntroduction: Ventilator-associated pneumonia (VAP) is one of the major hospital-acquired infections in the intensive care unit (ICU). The Centers for Disease Control and Prevention (CDC) made changes in the definitions of VAP. In this study, we aimed to prospectively evaluate patients in the tertiary-level chest diseases ICU between December 2016 and May 2017 in terms of ventilator-related events using the new surveillance criteria for patients requiring invasive mechanical ventilation. Materials and Methods: Patients in the chest diseases ICU were prospectively evaluated in terms of VAP development, and the incidence was calculated according to the old and new CDC criteria. Results: A total of 82 patients (31 women, 51 men) were followed up in the chest diseases ICU. Twenty-four patients who met the new surveillance criteria (survived >4 days) with 1632 patient-days and 601 ventilator days were included in the study. The incidences of VAP according to the old and new criteria were 31.6 and 1.6 per 1000 ventilator days, respectively. Conclusion: Our data suggest that new CDC definitions underdiagnose pneumonia in the daily practice. We may conclude that it does not seem rational to switch to the newer VAP definitions in the daily practice from the elder CDC definitions.en_US
dc.identifier.doi10.4274/mjima.galenos.2021.2021.7
dc.identifier.issn2147-673X
dc.identifier.issn2147-673Xen_US
dc.identifier.scopus2-s2.0-85131107614en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.urihttps://doi.org/10.4274/mjima.galenos.2021.2021.7
dc.identifier.urihttps://hdl.handle.net/11454/78779
dc.identifier.volume11en_US
dc.identifier.wosWOS:000789479100001en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherGalenos Yayinciliken_US
dc.relation.ispartofMediterranean Journal Of Infection Microbes And Antimicrobialsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectPreventionen_US
dc.subjectdefinitionen_US
dc.subjecthealthcare-associated infectionsen_US
dc.subjectnosocomial infectionsen_US
dc.subjecthospital epidemiologyen_US
dc.subjectinfection controlen_US
dc.titleAre We Close to Zeroing the Ventilator-associated Pneumonia Rate?en_US
dc.title.alternativeYoksa Ventilatör İlişkili Pnömoni Hızını Sıfırlamaya Yaklaşıyor muyuz?en_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu